Sales Director Neuroscience Germany

• Co-developing go-to market strategy for Germany as commercial hire No. 1 in Europe
• Launch of Zolgensma® in SMA
• Establishing first available Gene Therapy in SMA in specialised treatment centres (German Muscle Centres).

• Ensure successful outcomes of all local market access & contracting related processes in the D-A-CH region to ensure uninterrupted product supply to patients
• Successfully establishing a new supply-chain via office based pharmacies in Germany after failed GKV price negotiations and going off-market strategy
• Closely collaborate with the local commercial teams and individual health insurances to facilitate and ensure cost coverage in a continuous and timely fashion
• Monitor and track performance (revenues, patient numbers) and control adherence
• Identify sales deviations early and pro-actively initiate corrective measures (with/ via the local commercial teams) as needed
• Monitor contractual frameworks (expiry dates) with health insurances and act early (with/ via the commercial teams) if needed
• Supervise the delivery of the annual forecasts and quarterly LEs and ensure alignment of numbers with regional (D-A-CH) and global medical / marketing plans
• Sales vs. target: 2018: 108%

• East Germany & Austria, Short Bowel Syndrome
• Developed and initiated a patient search project for SBS-patients together with the University of Dresden
• Developed questionnaire for patient search project
• Implemented and managed a regional patient support nurse project
• Accompanied reimbursement in Austria
• Set up unique regional reimbursement and prescription model for SBS patients with a private practicing nutrition HCP
• Orphan drug product launch from “Day #1” on
• Developed congress and daily advertorials in cross collaboration with medical department and customers
• Sales vs. target: 2015: Germany No. 1 in Europe, My territory: 110%

• East Germany Childhood epilepsy, neurology
• Developed and initiated regional educational events
• Initiated and organised in collaboration with a national KOL and two regional KOLs the “1. Berlin-Brandenburger Epilepsy Symposium”
• Co-developed a “how to use” – sheet for midazolam emergency use

ViroPharma was 2014 acquired by Shire

• North & East Germany
• Hiring, leading and coaching a team of 9 sales reps in the breakthrough cancer pain market.
• Developing & executing go-to market strategy for PecFent®
• Launch of PecFent®

Different sales rep positions on a project basis via sales rep rental service companies in neurology, dermatology, rheumatology & cardiac diseases